Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Keros Therapeutics, Inc.(KROS) | 1,486,461 | 5,389,264 | +3,902,803 | $15.15M | $71.95M | 11.68% | +$56.80M |
| Protagonist Therapeutics Inc | 939,669 | 948,069 | +8,400 | $45.44M | $52.40M | 8.51% | +$6.96M |
| Ea Series TrustALPHA ARCH 1 3 ALPHA ARCH 1-3 | 337,125 | 337,125 | 0 | $37.59M | $37.99M | 6.17% | +$401.2K |
| Zai Lab LimitedADR(ZLAB) | 940,858 | 850,437 | -90,421 | $34.00M | $29.74M | 4.83% | -$4.26M |
| ABIVAX Société AnonymeADS(ABVX) | 2,210,019 | 3,071,340 | +861,321 | $13.81M | $23.50M | 3.82% | +$9.68M |
| Roivant Sciences Ltd.SHS(ROIV) | 3,483,404 | 1,940,797 | -1,542,607 | $35.15M | $21.87M | 3.55% | -$13.27M |
| Prothena Corp PlcSHS SHS | 0 | 3,375,009 | +3,375,009 | $0 | $20.49M | 3.33% | +$20.49M |
| Cytokinetics, Incorporated(CYTK) | 390,729 | 582,147 | +191,418 | $15.70M | $19.23M | 3.12% | +$3.53M |
| State Street SPDR S&P 500 ETF TrustTR UNIT(SPY) | 0 | 22,684 | +22,684 | $0 | $14.02M | 2.28% | +$14.02M |
| CG Oncology, Inc.(CGON) | 301,134 | 523,216 | +222,082 | $7.37M | $13.60M | 2.21% | +$6.23M |
| Spdr Series TrustBLOOMBERG 1 3 MO ST STR BLO 1 ETF | 135,585 | 135,585 | 0 | $12.44M | $12.44M | 2.02% | $0 |
| BridgeBio Pharma, Inc.(BBIO) | 339,635 | 259,659 | -79,976 | $11.74M | $11.21M | 1.82% | -$529.1K |
| Inhibikase Therapeutics, Inc.(IKT) | 5,122,105 | 5,122,105 | 0 | $11.22M | $9.99M | 1.62% | -$1.23M |
| Septerna, Inc.(SEPN) | 720,848 | 847,227 | +126,379 | $4.17M | $8.96M | 1.45% | +$4.78M |
| Arbutus Biopharma Corporation(ABUS) | 1,879,114 | 2,825,773 | +946,659 | $6.56M | $8.73M | 1.42% | +$2.17M |
| 89bio Inc | 804,220 | 875,983 | +71,763 | $5.85M | $8.60M | 1.40% | +$2.76M |
| Immunovant, Inc.(IMVT) | 968,866 | 535,066 | -433,800 | $16.56M | $8.56M | 1.39% | -$8.00M |
| Savara Inc.(SVRA) | 1,360,291 | 3,600,670 | +2,240,379 | $3.77M | $8.21M | 1.33% | +$4.44M |
| Xenon Pharmaceuticals Inc.(XENE) | 127,548 | 259,503 | +131,955 | $4.28M | $8.12M | 1.32% | +$3.84M |
| BioAge Labs, Inc.(BIOA) | 971,100 | 1,937,123 | +966,023 | $3.65M | $8.00M | 1.30% | +$4.35M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.72M | $7.96M | 1.29% | +$240.0K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 1,471,587 | 1,205,101 | -266,486 | $5.21M | $7.72M | 1.25% | +$2.52M |
| CytomX Therapeutics, Inc.(CTMX) | 47,036 | 3,081,414 | +3,034,378 | $29.9K | $6.99M | 1.14% | +$6.96M |
| Taysha Gene Therapies, Inc.(TSHA) | 1,066,309 | 3,009,870 | +1,943,561 | $1.48M | $6.95M | 1.13% | +$5.47M |
| Sage Therapeutics Inc | 742,495 | 721,599 | -20,896 | $5.90M | $6.58M | 1.07% | +$678.1K |
| Rapt Therapeutics Inc | 0 | 783,217 | +783,217 | $0 | $6.27M | 1.02% | +$6.27M |
| Aa Mission Acquisition CorpCL A | 578,359 | 578,359 | 0 | $6.03M | $6.03M | 0.98% | -$5.8K |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 148,461 | +148,461 | $0 | $5.87M | 0.95% | +$5.87M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 523,767 | 345,878 | -177,889 | $8.05M | $5.80M | 0.94% | -$2.25M |
| Oaktree Acquisition Corp IiiUNIT 10 04 2029 UNIT 10/04/2029 | 516,482 | 516,482 | 0 | $5.39M | $5.48M | 0.89% | +$87.8K |
| Verve Therapeutics Inc | 0 | 469,018 | +469,018 | $0 | $5.27M | 0.86% | +$5.27M |
| Revolution Medicines, Inc.(RVMD) | 177,136 | 134,136 | -43,000 | $6.26M | $4.93M | 0.80% | -$1.33M |
| Helix Acquisition Corp IiCL A | 469,729 | 442,615 | -27,114 | $5.31M | $4.70M | 0.76% | -$607.4K |
| Ishares Tr1 3 YR TREAS BD | 103,337 | 53,337 | -50,000 | $8.55M | $4.42M | 0.72% | -$4.13M |
| Rezolute, Inc.(RZLT) | 1,116,047 | 989,297 | -126,750 | $3.24M | $4.41M | 0.72% | +$1.18M |
| BridgeBio Pharma, Inc.NOTE 2 250 2 0(BBIO) | 0 | 0 | 0 | $4.03M | $4.19M | 0.68% | +$155.3K |
| Mineralys Therapeutics, Inc.(MLYS) | 263,425 | 302,125 | +38,700 | $4.18M | $4.09M | 0.66% | -$95.4K |
| Centessa Pharmaceuticals PlcADS | 216,166 | 296,766 | +80,600 | $3.11M | $3.90M | 0.63% | +$791.0K |
| Monopar Therapeutics Inc.(MNPR) | 100,774 | 100,974 | +200 | $3.67M | $3.61M | 0.59% | -$56.3K |
| Sarepta Therapeutics, Inc.(SRPT) | 122,921 | 210,313 | +87,392 | $7.84M | $3.60M | 0.58% | -$4.25M |
| Ardelyx Inc | 490,743 | 915,130 | +424,387 | $2.41M | $3.59M | 0.58% | +$1.18M |
| Third Harmonic Bio Inc | 100,000 | 622,873 | +522,873 | $347.0K | $3.38M | 0.55% | +$3.04M |
| Vaxcyte, Inc.(PCVX) | 12,800 | 98,032 | +85,232 | $483.3K | $3.19M | 0.52% | +$2.70M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 36,890 | 45,390 | +8,500 | $1.95M | $2.87M | 0.47% | +$914.1K |
| Verona Pharma PlcADS | 20,000 | 28,450 | +8,450 | $1.27M | $2.69M | 0.44% | +$1.42M |
| BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO) | 0 | 0 | 0 | $2.28M | $2.49M | 0.40% | +$205.7K |
| Alector Inc | 380,330 | 1,723,526 | +1,343,196 | $467.8K | $2.41M | 0.39% | +$1.95M |
| Viridian Therapeutics, Inc.(VRDN) | 79,000 | 170,598 | +91,598 | $1.06M | $2.38M | 0.39% | +$1.32M |
| A Spac Iii Acquisition CorpCL A ORD SHS CL A | 215,000 | 215,000 | 0 | $2.16M | $2.20M | 0.36% | +$40.9K |
| CorMedix Inc.(CRMD) | 0 | 175,000 | +175,000 | $0 | $2.16M | 0.35% | +$2.16M |
| Newamsterdam Pharma Company ORDINARY SHARES | 0 | 112,359 | +112,359 | $0 | $2.03M | 0.33% | +$2.03M |
| Delcath Systems, Inc.(DCTH) | 149,385 | 149,385 | 0 | $1.90M | $2.03M | 0.33% | +$130.0K |
| Anteris Technologies Global Corp.(AVR) | 1,678,063 | 531,515 | -1,146,548 | $6.11M | $2.01M | 0.33% | -$4.09M |
| Blueprint Medicines Corp | 0 | 15,000 | +15,000 | $0 | $1.92M | 0.31% | +$1.92M |
| Viking Therapeutics, Inc.(VKTX) | 59,413 | 67,813 | +8,400 | $1.43M | $1.80M | 0.29% | +$362.2K |
| Akero Therapeutics Inc | 71,143 | 33,143 | -38,000 | $2.88M | $1.77M | 0.29% | -$1.11M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 1,361 | 3,361 | +2,000 | $863.2K | $1.76M | 0.29% | +$901.3K |
| REGENXBIO Inc.(RGNX) | 350,352 | 207,818 | -142,534 | $2.51M | $1.71M | 0.28% | -$798.8K |
| Dynavax Technologies Corp | 170,000 | 170,000 | 0 | $2.20M | $1.69M | 0.27% | -$518.5K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 5,424 | 34,314 | +28,890 | $211.9K | $1.62M | 0.26% | +$1.41M |
| Oruka Therapeutics, Inc.(ORKA) | 132,780 | 142,780 | +10,000 | $1.36M | $1.60M | 0.26% | +$238.2K |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 41,412 | 56,540 | +15,128 | $919.8K | $1.56M | 0.25% | +$644.7K |
| Crinetics Pharmaceuticals In | 53,125 | 53,125 | 0 | $1.78M | $1.53M | 0.25% | -$253.9K |
| Tectonic Therapeutic, Inc.(TECX) | 62,603 | 73,505 | +10,902 | $1.11M | $1.46M | 0.24% | +$351.8K |
| Soleno Therapeutics Inc | 18,830 | 17,330 | -1,500 | $1.35M | $1.45M | 0.24% | +$106.5K |
| Janux Therapeutics, Inc.(JANX) | 153,767 | 62,088 | -91,679 | $4.15M | $1.43M | 0.23% | -$2.72M |
| Scholar Rock Holding Corporation(SRRK) | 157,079 | 39,677 | -117,402 | $5.05M | $1.41M | 0.23% | -$3.64M |
| Astria Therapeutics Inc | 641,690 | 249,646 | -392,044 | $3.43M | $1.34M | 0.22% | -$2.09M |
| Alkermes plcSHS(ALKS) | 0 | 45,000 | +45,000 | $0 | $1.29M | 0.21% | +$1.29M |
| Vir Biotechnology, Inc.(VIR) | 250,000 | 250,000 | 0 | $1.62M | $1.26M | 0.20% | -$360.0K |
| Agios Pharmaceuticals, Inc.(AGIO) | 27,900 | 35,900 | +8,000 | $817.5K | $1.19M | 0.19% | +$376.6K |
| Celldex Therapeutics, Inc.(CLDX) | 14,600 | 57,466 | +42,866 | $265.0K | $1.17M | 0.19% | +$904.4K |
| Springworks Therapeutics Inc | 207,778 | 24,082 | -183,696 | $9.17M | $1.13M | 0.18% | -$8.04M |
| Establishment Labs Holdings Inc.(ESTA) | 8,000 | 25,000 | +17,000 | $326.4K | $1.07M | 0.17% | +$741.3K |
| Acumen Pharmaceuticals, Inc.(ABOS) | 146,183 | 916,183 | +770,000 | $160.8K | $1.06M | 0.17% | +$902.0K |
| Cidara Therapeutics Inc | 20,938 | 21,522 | +584 | $451.0K | $1.05M | 0.17% | +$597.3K |
| Zura Bio LimitedCL A(ZURA) | 2,801,184 | 997,547 | -1,803,637 | $3.61M | $1.05M | 0.17% | -$2.57M |
| BEST SPAC I Acquisition Corp.UNIT 05 27 2030(BSAA) | 0 | 100,000 | +100,000 | $0 | $1.00M | 0.16% | +$1.00M |
| argenx SEADR(ARGX) | 600 | 1,759 | +1,159 | $355.1K | $969.6K | 0.16% | +$614.5K |
| Merus N V | 66,960 | 18,313 | -48,647 | $2.82M | $963.3K | 0.16% | -$1.86M |
| Aldeyra Therapeutics, Inc.(ALDX) | 211,579 | 249,920 | +38,341 | $1.22M | $957.2K | 0.16% | -$259.4K |
| Pfizer Inc.(PFE) | 41,050 | 39,400 | -1,650 | $1.04M | $955.1K | 0.16% | -$85.2K |
| Arvinas, Inc.(ARVN) | 313,354 | 128,767 | -184,587 | $2.20M | $947.7K | 0.15% | -$1.25M |
| Arcellx Inc COMMON STOCK | 13,962 | 13,962 | 0 | $915.9K | $919.4K | 0.15% | +$3.5K |
| Nuvalent Inc | 0 | 11,842 | +11,842 | $0 | $903.5K | 0.15% | +$903.5K |
| Tenax Therapeutics, Inc.(TENX) | 68,741 | 155,557 | +86,816 | $450.3K | $896.0K | 0.15% | +$445.8K |
| Surgery Partners, Inc.(SGRY) | 40,000 | 40,000 | 0 | $950.0K | $889.2K | 0.14% | -$60.8K |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 56,300 | 55,200 | -1,100 | $717.3K | $872.2K | 0.14% | +$154.9K |
| Korro Bio, Inc.(KRRO) | 68,715 | 68,815 | +100 | $1.20M | $859.5K | 0.14% | -$336.8K |
| Keen Vision Acquisition CorporationSHS(KVACF) | 0 | 75,000 | +75,000 | $0 | $852.8K | 0.14% | +$852.8K |
| Vistagen Therapeutics, Inc.(VTGN) | 420,765 | 420,765 | 0 | $1.05M | $841.5K | 0.14% | -$210.4K |
| Apogee Therapeutics Inc | 104,853 | 18,070 | -86,783 | $3.92M | $784.8K | 0.13% | -$3.13M |
| Wave Life Sciences, Inc.SHS(WVE) | 23,100 | 114,814 | +91,714 | $186.6K | $746.3K | 0.12% | +$559.6K |
| KALA BIO, Inc.(KALA) | 298,955 | 149,830 | -149,125 | $1.71M | $713.2K | 0.12% | -$999.8K |
| Larimar Therapeutics, Inc.(LRMR) | 0 | 237,605 | +237,605 | $0 | $686.7K | 0.11% | +$686.7K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 241,800 | 275,800 | +34,000 | $1.61M | $675.7K | 0.11% | -$937.1K |
| Kezar Life Sciences Inc COM NEW | 147,404 | 147,404 | 0 | $719.3K | $675.1K | 0.11% | -$44.2K |
| Xencor, Inc.(XNCR) | 398,152 | 85,826 | -312,326 | $4.24M | $674.6K | 0.11% | -$3.56M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 168,765 | 166,799 | -1,966 | $1.18M | $662.2K | 0.11% | -$515.8K |
| Biogen Inc.(BIIB) | 4,500 | 5,100 | +600 | $615.8K | $640.5K | 0.10% | +$24.7K |